HomeLiterature Search
Popular searches
Microsatellite Instability Identifies a Rare but Clinically Relevant Subset of …

Saoud(C),Vanderbilt(C),Benhamida(J),Morris(C… Clin Cancer Res 2026-07-30

...MSH2 and MLH1 predominated in Lynch syndrome-associated cases. TP53 (83%) and NF1 (51%) were frequent somatic co-alterat...

The ATF2-KNSTRN Axis Harnesses Lactate to Modulate MLH1/MSH2 Expression and Gem…

Wu(H),Han(K),Zheng(B),Xiao(T) FASEB J 2026-07-15

...MSH2, thereby impairing DNA damage repair capacity correlated positively with the expression of pivotal genes in these p...

Targeted Next-Generation Sequencing-Based Mutational Signature Analysis in Hype…

Kim(SU),Lee(YS),Jeun(SS),Park(JS),Lee(D),Kan… Pathobiology 2026-07-07

...MSH2 deficiency. The remaining 26 non-hypermutated tumors had sparse mutation counts, limiting reliable signature interp...

LINE-1 insertion intermediates recombine with one another or with DNA breaks to…

Mendez-Dorantes(C),Kalinowski(JC),Burn(A),Sc… Nat Commun 2026-08-01

...MSH2 when the recombining sequences contain mismatches. Given the repetitive nature of our genome, these findings highli...

Differential expression of PTEN, pAKT1, pRPS6, and mismatch repair proteins in …

Inan(MA),Urganci(M),Simsek(B),Coskun(M),Sahi… Virchows Arch 2026-06-00

...MSH2, and MSH6) was assessed to evaluate MSI status. Gonadotroph tumors were the most common subtype (45.5%). Statistica...

Mismatch Repair Deficiency in Upper Gastrointestinal and Pancreaticobiliary Can…

Davidson(S),Gibson(JA) Arch Pathol Lab Med 2026-09-11

...MSH2 of MSH6 loss (9 of 91, 10%). Among the subset with MSI testing, MMRd by IHC and MSI were discordant in 16% (3 of 19...

Ultramutagenesis through Combined Msh2 Depletion and Proofreading-Deficient DNA…

Nguyen(AH),Li(V),Chen(WM),Kimberg(J),Davis(A… ACS Chem Biol 2026-09-11

...Msh2 with doxycycline-inducible expression of the proofreading-deficient PolεP286R mutant in murine small cell lung canc...

Case Report: Converting an immunologically "cold" tumor: exceptional response t…

Ni(C),Xu(J),Pang(Y),Xu(J) Front Immunol None

...MSH2, MSH6, PMS2) and confirmed by next-generation sequencing (NGS). Following disease progression on first-line gemcita...

Cytological Diagnosis of Primary Cardiac Angiosarcoma Presenting With Multiple …

Xu(C),Gong(Y) Diagn Cytopathol 2026-09-00

...MSH2 (c.14C>A, p.Pro5Gln) with a variant allele frequency (VAF) of 48%, confirming the feasibility of CB as an alternati...

Case of complete response to immunotherapy in MMR-deficient prostate cancer ass…

Tsai(AK),Lozada(JR),Kennedy(PR),Moline(D),Pa… Cell Rep Med 2026-07-21

...MSH2 and MSH6 genomic deletions with ultrahigh TMB (>250 mutations/megabase) in whom pembrolizumab resulted in a strikin...

Previous 1 2 3 4 5 6 7 8 9 Next Vol. 5 / of 279

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com